We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
ESTRO
Menu
  • Corporate Members
  • E-Library
  • Twitter
  • Linked In
  • Facebook
  • Instagram
  • Join
  • MyESTRO
Search Opener
  • About ESTRO
  • Membership
  • School
  • Workshops
  • Congresses
  • Science
  • Education
  • Advocacy
  • Corporate Members
  • E-Library
  1. Home
  2. About ESTRO
  3. Newsroom
  4. Newsletter
  5. Read it before your patients

Achieve recognition of all radiotherapy professions

Read it before your patients
  • 29/12/2023

    Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer

  • 21/12/2023

    Developing a predictive nomogram and web-based survival calculator for locally advanced hypopharyngeal cancer

  • 12/12/2023

    Pericardial irradiation dose may be strongly associated with grade 4 lymphopenia

  • 01/12/2023

    Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631)

  • 20/11/2023

    Deep Learning of Multimodal Ultrasound: Stratifying the Response to Neoadjuvant Chemotherapy in Breast Cancer Before Treatment

  • 10/11/2023

    Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer

News Pages: 11 12 13 14 15 16 17 18 19 20
  • Newsletter 2019
  • Newsletter 2018
  • Newsletter 2017

Corner Editor: Philippe Lambin

Submit your article

Corner Editor: Evert van Limbergen

Submit your article
  • Contact
  • Privacy Statement
  • Sitemap
  • Careers
  • FAQ
  • Twitter
  • Linked In
  • Facebook
  • Instagram

© The European SocieTy for Radiotherapy and Oncology. All rights reserved. ESTRO Avenue Marnix 17, 1000 Brussels . +32 477 271 125.